NLSCX
Price
$18.83
Change
-$0.02 (-0.11%)
Updated
Dec 3 closing price
Net Assets
7.99B
RLSFX
Price
$15.21
Change
+$0.02 (+0.13%)
Updated
Dec 3 closing price
Net Assets
35.65M
Interact to see
Advertisement

NLSCX vs RLSFX

Header iconNLSCX vs RLSFX Comparison
Open Charts NLSCX vs RLSFXBanner chart's image
Neuberger Berman Long Short C
Price$18.83
Change-$0.02 (-0.11%)
VolumeN/A
Net Assets7.99B
RiverPark Long/Short Opportunity Retail
Price$15.21
Change+$0.02 (+0.13%)
VolumeN/A
Net Assets35.65M
NLSCX vs RLSFX Comparison Chart in %
View a ticker or compare two or three
VS
NLSCX vs. RLSFX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NLSCX is a Buy and RLSFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NLSCX has more cash in the bank: 8B vs. RLSFX (35.7M). NLSCX (0.00) and RLSFX (0.00) have matching dividends . NLSCX was incepted earlier than RLSFX: NLSCX (14 years) vs RLSFX (14 years). NLSCX (2.43) is less costly to investors than RLSFX (2.17). NLSCX is a more actively managed with annual turnover of: 48.00 vs. RLSFX (10.00). NLSCX (1000) and RLSFX (1000) have matching initial minimum investment requirements. NLSCX annual gain was more profitable for investors over the last year : 6.13 vs. RLSFX (5.59). NLSCX return over 5 years is better than : 15.78 vs. RLSFX (-11.90).
NLSCXRLSFXNLSCX / RLSFX
Total Expense Ratio2.432.00122%
Annual Report Gross Expense Ratio2.432.17112%
Fund Existence14 years14 years-
Gain YTD6.6148.23880%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets8B35.7M22,395%
Annual Yield % from dividends0.000.00-
Returns for 1 year6.135.59110%
Returns for 3 years17.0067.7025%
Returns for 5 years15.78-11.90-133%
Returns for 10 years45.2243.31104%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OROVF17.68N/A
N/A
Orient Overseas International Ltd.
REMYF45.00N/A
N/A
Remy Cointreau SA
SLNCF1.80N/A
N/A
Silence Therapeutics, Plc.
AILLN79.25N/A
N/A
Ameren Illinois Company
MYRUF0.24N/A
N/A
Myriad Uranium Corp.